- Aug 21, 2003
Phase 2 data looks good. Hopefully the phase 3 will be released in a week or two. As long as it all works the more the merrier.Let's hope for more than 1 yr. Time will tell.
The Johnson and Johnson vaccine in the pipeline is a one shot that currently shows more antibodies produced than 2 shot ones and requires nothing more than regular refrigeration. Sounds promising.
In an early safety study, Johnson & Johnson's one-shot COVID-19 vaccine produced immune proteins in more than 90% of participants.www.latimes.com